Sanara MedTech Inc.
SMTI
$23.17
-$0.47-1.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.41% | 19.01% | 30.55% | 34.29% | 34.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.41% | 19.01% | 30.55% | 34.29% | 34.65% |
| Cost of Revenue | -5.88% | -7.60% | 2.82% | 7.73% | 6.14% |
| Gross Profit | 19.66% | 21.76% | 33.58% | 37.33% | 38.25% |
| SG&A Expenses | 10.12% | 10.78% | 17.23% | 19.83% | 25.76% |
| Depreciation & Amortization | 11.16% | -0.18% | -34.93% | -37.48% | -32.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.95% | 10.15% | 13.63% | 15.15% | 19.18% |
| Operating Income | 473.65% | 797.43% | 210.24% | 152.51% | 119.39% |
| Income Before Tax | 44.24% | 36.34% | 84.93% | 71.81% | 32.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 44.24% | 36.34% | 84.93% | 71.81% | 32.39% |
| Earnings from Discontinued Operations | -293.20% | -572.64% | -1,267.18% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -79.34% | -91.26% | -94.03% | -95.08% | -79.65% |
| Net Income | -193.82% | -288.66% | -348.29% | -51.36% | -133.72% |
| EBIT | 473.65% | 797.43% | 210.24% | 152.51% | 119.39% |
| EBITDA | 151.73% | 283.10% | 715.27% | 287.72% | 226.99% |
| EPS Basic | -189.91% | -282.11% | -339.97% | -49.09% | -128.37% |
| Normalized Basic EPS | 98.68% | 74.22% | 95.57% | 85.86% | 65.20% |
| EPS Diluted | -181.99% | -272.26% | -328.60% | -49.09% | -128.37% |
| Normalized Diluted EPS | 97.31% | 73.55% | 95.23% | 85.86% | 65.20% |
| Average Basic Shares Outstanding | 1.03% | 1.08% | 1.70% | 1.87% | 2.18% |
| Average Diluted Shares Outstanding | 2.71% | 1.94% | 2.57% | 1.87% | 2.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |